Home | Site Map
 
 
[.:Partners:.]

[.:Contenuti:.]
INHIBITOR

Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers EurekAlert!
Prague, Czech Republic: Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers.
S*BIO Presents Data at EORTC on Lead Histone Deacetylase Inhibitor SB939 PR Newswire via Yahoo! Finance
S*BIO Pte Ltd, today announced the presentation of data on their lead histone deacetylase inhibitor, SB939, during the scientific sessions at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Phase I Data For Exelixis' Kit Inhibitor XL820 Presented At EORTC Medical News Today
Exelixis, Inc. (Nasdaq: EXEL) announces that preliminary Phase I results were reported today from an ongoing trial of XL820, an oral small molecule compound which inhibits KIT, PDGF and VEGF and is designed to inhibit tumor growth and angiogenesis. [click link for full article]
Mom's SSRI use may raise risk of birth defects Reuters via Yahoo! News
The use of selective serotonin reuptake inhibitor (SSRI) antidepressant drugs early in pregnancy seems to moderately raise the risk of congenital malformations in offspring, suggests the results of a Danish population-based cohort study.
Data From MethylGene's Oncology Programs to be Reported at the 18th EORTC-NCI-AACR Cancer Symposium in Prague Market Wire via Yahoo! Finance
MethylGene Inc., today announced that clinical data from one of its Phase I trials for its histone deacetylase inhibitor, MGCD0103, as well as preclinical data for its lead c-MET, multi-targeted kinase inhibitor, will be presented at two poster sessions at the 18th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," in Prague, Czech Republic, on November 7th to 10th.
Exelixis Presents Preliminary Phase I XL184 Data PR Newswire via Yahoo! Finance
Exelixis, Inc. announces that the first results from an ongoing Phase I trial of XL184, a small molecule inhibitor of multiple receptor tyrosine kinases implicated in tumor cell growth and angiogenesis, including c-MET and VEGF were reported today.
PTC Therapeutics Initiates A Phase 1 Multiple-Dose Study Of Its Novel VEGF Inhibitor, PTC299 Medical News Today
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery and development of small-molecule drugs targeting post-transcriptional control mechanisms, today announced the initiation of a Phase 1 multiple-dose study to evaluate escalating dose levels of PTC299 in healthy volunteers. [click link for full article]
Health Canada approves new cox-2 inhibitor CTV.ca
Two years after the one-time wonder drugs known as cox-2 inhibitors took a major hit in the public confidence department, drug giant Novartis is bringing a new member of this class to market in Canada.
InterMune to Present at the ThinkEquity Partners ThinkTank PR Newswire via Yahoo! Finance
InterMune, Inc. announced today that Lawrence M. Blatt, Ph.D., Chief Scientific Officer of InterMune, will present an overview on ITMN-191, the company's lead hepatitis C virus protease inhibitor compound at the ThinkEquity Partners ThinkTank in New York City on November 10, 2006 at 9:00am EST.
Police crack down on dodgy data Silicon.com
Case study: Humberside police says 'ello 'ello 'ello to new data quality system


ACE inhibitor: Definition and Much More from Answers.com
ACE inhibitor n. Any of a class of drugs that cause vasodilation and are used to treat hypertension and heart failure.
CHFpatients.com - Ace Inhibitors For Heart Failure Explained
CHFpatients.com - Ace inhibitors explained in plain English - the primary drug treatment for heart failure.
COX-2 Inhibitor Use Halted in Cancer Prevention Trial, December 17
The National Institutes of Health (NIH) announced today that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all
eMedicine - Toxicity, Monoamine Oxidase Inhibitor : Article by
Toxicity, Monoamine Oxidase Inhibitor - Neurotransmitters are generally monoamines. When released into the synaptic space, neurotransmitters are either
PROLYSIS
Welcome to PROLYSIS home page, intended as a Web resource for those interested in proteases and their natural or synthetic inhibitors.
Rust Inhibitor Coating & Products Rust Paint & Preventative
Stop Rust and Corrosion with Rust Bullet-a rust repair rust remover corrosion inhibitor, which acts as a rust paint corrosion solution industrial coating.
MedlinePlus Drug Information: Antidepressants, Monoamine Oxidase
Antidepressants Monoamine Oxidase (MAO) Inhibitor(Systemic) Monoamine oxidase (MAO) inhibitors are used to relieve certain types of mental depression.
PLoS Pathogens: Carrageenan Is a Potent Inhibitor of
Despite these apparent chemical similarities to the noninhibitory chondroitin 4-sulfate, κ-carrageenan was an extremely potent inhibitor,
Cerca con Google


 
 
All rights reserved. info sol sito email Tutti i diritti sono riservati.